Lumentum
LITE
1,111.07
-22.33
-1.97%
Lumentum
US · LITE
#272 by market cap
Listed 2015
1,111.07
-22.33
-1.97%
Live - 5344 symbols - heartbeat 114s ago
· 2026-10-08 08:30
Pre-market
1,068.62
-3.82%
After-hours
1,112.94
+0.17%
Overnight
1,085.82
-2.27%
- Market cap
- 100.64B
- P/E (TTM)i
- -11.95
- P/Bi
- 21.67
- EPSi
- -92.96
- Div yieldi
- 0.00%
- 52W posi
- 97%
Reader sentiment
Are you bullish or bearish on LITE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 22.11, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +83.22% YoY
Margins
- Gross margin
- 41.67%
- Operating margin
- 17.79%
- Net margin
- -230.10%
Key ratios & quality
- Enterprise valuei
- 99.56B
- Altman Z-Scorei
- 22.11
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.57B | 1.68B | 1.74B | 1.71B | 1.77B | 1.36B | 1.65B | 3.01B |
| Gross profit | 425.90M | 650.20M | 783.10M | 788.60M | 569.00M | 251.50M | 459.90M | 1.26B |
| Selling & admin expenses | 200.30M | 235.20M | 241.40M | 265.70M | 348.80M | 310.70M | 348.20M | 363.20M |
| Research & development | 184.60M | 198.60M | 214.50M | 220.70M | 307.80M | 302.20M | 303.90M | 356.50M |
| Operating profit | 41.00M | 216.40M | 327.20M | 302.20M | -87.60M | -361.40M | -192.20M | 536.20M |
| Pretax profit | -33.30M | 174.30M | 463.10M | 235.10M | -102.40M | -405.70M | -172.10M | -7.17B |
| Tax | 3.10M | 38.80M | 65.80M | 36.20M | 29.20M | 140.80M | -198.00M | -237.70M |
| Net profit | -36.40M | 135.50M | 397.30M | 198.90M | -131.60M | -546.50M | 25.90M | -6.94B |
| Basic EPS | -1 | 2 | 5 | 3 | -2 | -8 | 0 | -93 |
| Diluted EPS | -0.54 | 1.75 | 5.07 | 2.68 | -1.93 | -8.12 | 0.37 | -92.96 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 425.20M | 480.70M | 533.80M | 665.50M | 808.40M | 1.01B |
| Gross profit | 122.50M | 159.90M | 181.50M | 240.10M | 357.00M | 477.30M |
| Selling & admin expenses | 112.00M | 83.60M | 85.10M | 96.10M | 90.80M | 91.20M |
| Research & development | 75.90M | 79.50M | 81.40M | 80.10M | 90.60M | 104.40M |
| Operating profit | -65.40M | -3.20M | 15.00M | 63.90M | 175.60M | 281.70M |
| Pretax profit | -39.20M | -11.40M | 5.20M | 96.50M | 183.80M | -7.46B |
| Tax | 4.90M | -224.70M | 1.00M | 18.30M | 39.60M | -296.60M |
| Net profit | -44.10M | 213.30M | 4.20M | 78.20M | 144.20M | -7.16B |
| Basic EPS | -1 | 3 | 0 | 1 | 2 | -85 |
| Diluted EPS | -0.64 | 2.96 | 0.05 | 0.89 | 1.50 | -84.65 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.33B | 2.05B | 2.44B | 3.14B | 2.78B | 1.59B | 1.72B | 4.16B |
| Cash & ST investments | 768.50M | 1.55B | 1.95B | 2.55B | 2.01B | 887.00M | 877.10M | 2.74B |
| Inventory | 228.80M | 188.90M | 196.40M | 250.10M | 408.60M | 398.40M | 470.10M | 691.60M |
| Total assets | 2.72B | 3.29B | 3.55B | 4.16B | 4.63B | 3.93B | 4.22B | 7.31B |
| Total current liabilities | 294.00M | 283.00M | 664.60M | 716.50M | 633.80M | 269.30M | 392.80M | 2.48B |
| Short-term debt | 5.40M | 11.40M | 402.50M | 421.10M | 326.00M | 13.40M | 22.00M | 1.61B |
| Long-term debt | 835.90M | 1.12B | 789.80M | 1.47B | 2.50B | 2.50B | 2.56B | 40.50M |
| Total liabilities | 1,219,500,000.00 | 1,543,400,000.00 | 1,578,800,000.00 | 2,287,200,000.00 | 3,276,300,000.00 | 2,974,600,000.00 | 3,084,000,000.00 | 2,663,600,000.00 |
| Total equity | 1.50B | 1.75B | 1.97B | 1.88B | 1.36B | 957.30M | 1.13B | 4.64B |
| Retained earnings | 129.10M | 64.60M | 220.90M | -129.10M | -340.60M | -887.10M | -861.20M | -7.80B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.67B | 1.72B | 2.09B | 2.28B | 4.40B | 4.16B |
| Cash & ST investments | 866.70M | 877.10M | 1.12B | 1.16B | 3.17B | 2.74B |
| Inventory | 422.90M | 470.10M | 531.60M | 570.40M | 632.80M | 691.60M |
| Total assets | 3.98B | 4.22B | 4.61B | 4.81B | 7.03B | 7.31B |
| Total current liabilities | 353.00M | 392.80M | 1.53B | 3.77B | 3.87B | 2.48B |
| Short-term debt | 21.60M | 22.00M | 1.09B | 3.25B | 3.25B | 1.61B |
| Long-term debt | 2.56B | 2.56B | 2.16B | 47.10M | 43.20M | 40.50M |
| Total liabilities | 3,095,500,000.00 | 3,084,000,000.00 | 3,832,300,000.00 | 3,958,700,000.00 | 4,054,500,000.00 | 2,663,600,000.00 |
| Total equity | 879.50M | 1.13B | 780.80M | 846.60M | 2.97B | 4.64B |
| Retained earnings | -1.07B | -861.20M | -857.00M | -778.80M | -634.60M | -7.80B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 330.10M | 524.30M | 738.70M | 459.30M | 179.80M | 24.70M | 126.30M | 751.40M |
| Depreciation & amortization | 157.50M | 191.90M | 177.10M | 167.10M | 255.60M | 290.30M | 256.70M | 267.00M |
| Free cash flow | 164.10M | 438.30M | 653.90M | 368.10M | 51.30M | -112.30M | -104.70M | 300.10M |
| Dividends paid | -700.00K | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -200.00M | -236.00M | -543.90M | -175.60M | 0 | 0 | -102.00M |
| Ending cash balance | 432.60M | 298.00M | 774.30M | 1.29B | 859.00M | 436.70M | 520.70M | 2.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1.60M | 64.00M | 57.90M | 126.70M | 203.80M | 363.00M |
| Depreciation & amortization | 60.10M | 61.10M | 62.20M | 64.60M | 66.60M | 73.60M |
| Free cash flow | -64.40M | 10.10M | -18.30M | 43.10M | 79.10M | 196.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 516.40M | 520.70M | 772.90M | 657.70M | 2.62B | 2.04B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -3.13 | 8.35 | 21.35 | 10.34 | -8.15 | -47.25 | 2.48 | -240.03 |
| ROA %i | -1.76 | 4.51 | 11.61 | 5.16 | -2.99 | -12.76 | 0.64 | -120.34 |
| ROIC %i | -1.20 | 6.47 | 14.62 | 7.45 | -3.38 | -14.67 | 0.45 | -138.64 |
| 5-year avg ROE %i | 1.59 | 3.45 | 7.86 | 13.63 | 5.75 | -3.07 | -4.25 | -56.52 |
| EBIT margin %i | 0.19 | 14.03 | 30.40 | 18.41 | -3.79 | -27.36 | -9.11 | -237.26 |
| FCF / sales %i | 10.48 | 26.11 | 37.52 | 21.49 | 2.90 | -- | -- | 9.96 |
| Current ratioi | 4.53 | 7.24 | 3.67 | 4.38 | 4.38 | 5.90 | 4.37 | 1.68 |
| Quick ratioi | 3.42 | 6.32 | 3.25 | 3.92 | 3.57 | 4.02 | 2.87 | 1.31 |
| Debt / assetsi | 30.97 | 36.12 | 34.91 | 46.51 | 62.04 | 65.10 | 61.82 | 22.87 |
| LT debt / equityi | 55.83 | 67.34 | 42.45 | 80.79 | 187.91 | 265.98 | 227.92 | 1.31 |
| Interest coveragei | 0.08 | 3.85 | 7.94 | 3.93 | -1.88 | -11.00 | -6.75 | -328.03 |
| Revenue CAGR (3Y) %i | 20.13 | 18.78 | 11.78 | 3.04 | 1.73 | -7.95 | -1.33 | 19.48 |
| Net income CAGR (3Y) %i | -- | -- | 16.99 | -- | -- | -- | -49.31 | -- |
| FCF CAGR (3Y) %i | 229.19 | -- | 61.83 | 30.90 | -51.08 | -- | -- | 80.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -42.79 | 2.48 | 13.42 | 29.27 | 22.79 | -240.03 |
| ROA %i | -10.76 | 0.64 | 2.62 | 5.74 | 7.98 | -120.34 |
| ROIC %i | -12.47 | 0.45 | 2.74 | 6.31 | 9.27 | -138.64 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -18.06 | -9.11 | -3.55 | 3.52 | 11.96 | -237.26 |
| FCF / sales %i | -- | -- | -- | -- | 4.58 | 9.96 |
| Current ratioi | 4.72 | 4.37 | 1.37 | 0.61 | 1.14 | 1.68 |
| Quick ratioi | 3.18 | 2.87 | 0.94 | 0.41 | 0.93 | 1.31 |
| Debt / assetsi | 65.66 | 61.82 | 71.11 | 69.15 | 47.15 | 22.87 |
| LT debt / equityi | 294.28 | 227.92 | 280.35 | 8.24 | 2.11 | 1.31 |
| Interest coveragei | -11.98 | -6.75 | -2.92 | 3.21 | 12.61 | -328.03 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Components is the largest reported line at 66.54% of revenue, across 2 reported segments.
- Systems follows at 33.46%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Components66.54%
Systems33.46%
Region
United States20.83%
Thailand20.79%
Hong Kong17.23%
Mexico14.72%
China9.45%
Other Asia-Pacific7.20%
EMEA5.87%
Japan3.47%
Other Americas0.44%
Quote time 2026-10-08 08:30:16 · For reference only, not investment advice and not tailored to your situation.